Drug Pipeline

Drug Pipeline Market Research Reports

1 . Drug Pipeline Market Research Reports Analysis and Trends

Discovering and bringing new drugs to mainstream commercial market typically takes an average of 10-15 years of research and clinical development efforts. Drug developers need to make sure safe and effective drug available for patient in quick time. The first step is to target the protein available in the patient’s body that is associated with microorganism causing a disease, through tracking of cellular network of proteins an appropriate target for a drug is selected. Through a series of trials, right drug candidate got chosen.
 
According to “NOVARTIS”, bringing a new drug in market takes 14 years of research and cost around USD 2 billion, 10K+ clinical trials out of these, one leads to successful drug development.
Titlesort ascending Published Pages Price
Zygomycosis (Mucormycosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 38 USD 2,000.00
Zygomycosis (Mucormycosis) (Infectious Disease) - Drugs in Development, 2021 Apr 30 2021 30 USD 2,000.00
Zinc Finger Protein GLI1 (Glioma Associated Oncogene or Oncogene GLI or GLI1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 35 USD 2,500.00
Zinc Finger Protein GLI1 (Glioma Associated Oncogene or Oncogene GLI or GLI1) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
Zinc Finger And SCAN Domain Containing Protein 4 (Zinc Finger Protein 494 or ZSCAN4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 35 USD 2,500.00
Zinc Finger And SCAN Domain Containing Protein 4 (Zinc Finger Protein 494 or ZSCAN4) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Dec 28 2022 216 USD 2,000.00
Zika Virus Infections - Pipeline Review, H2 2019 Dec 27 2019 244 USD 2,000.00
Zika Virus Infections - Pipeline Review, H1 2020 Jun 30 2020 274 USD 2,000.00
Zika Virus Infections - Pipeline Review, H1 2018 Jun 15 2018 200 USD 2,000.00
Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021 Dec 30 2021 258 USD 2,000.00
Zika Virus Envelope Protein (E) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 36 USD 2,500.00
Zika Virus Envelope Protein (E) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
Yellow Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Jul 29 2022 92 USD 2,000.00
Yellow Fever - Pipeline Review, H2 2020 Oct 30 2020 71 USD 2,500.00
Yellow Fever - Pipeline Review, H2 2019 Dec 27 2019 56 USD 2,000.00
Yellow Fever - Pipeline Review, H2 2018 Oct 16 2018 52 USD 2,000.00
Yellow Fever - Pipeline Review, H1 2020 Apr 30 2020 57 USD 2,000.00
Yellow Fever (Infectious Disease) - Drugs In Development, 2021 Jul 30 2021 77 USD 2,000.00
Xerostomia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 39 USD 2,000.00
Xerostomia - Pipeline Review, H2 2019 Nov 18 2019 37 USD 2,000.00
Xerostomia - Pipeline Review, H2 2018 Sep 28 2018 44 USD 2,000.00
Xerostomia - Pipeline Review, H1 2018 Mar 27 2018 41 USD 2,000.00
Xerostomia (Mouth And Dental Disorders) - Drugs in Development, 2021 Apr 30 2021 35 USD 2,000.00
Xanthine Dehydrogenase/Oxidase (Xanthine Dehydrogenase or Xanthine Oxidase or Xanthine Oxidoreductase or XDH or EC 1.17.1.4 or EC 1.17.3.2) - Drugs in Development, 2021 Apr 30 2021 45 USD 3,000.00
Xanthine Dehydrogenase-Oxidase (Xanthine Dehydrogenase or Xanthine Oxidase or Xanthine Oxidoreductase or XDH or EC 1.17.1.4 or EC 1.17.3.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 50 USD 2,500.00
X-Linked SCID Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 38 USD 2,000.00
X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 Apr 30 2021 35 USD 2,000.00
X Linked Retinitis Pigmentosa GTPase Regulator (Retinitis Pigmentosa 15 or Retinitis Pigmentosa 3 GTPase Regulator or RPGR) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 246 USD 2,000.00
Wounds - Pipeline Review, H2 2019 Dec 27 2019 224 USD 2,000.00
Wounds - Pipeline Review, H1 2020 Jun 30 2020 255 USD 2,000.00
Wounds (Dermatology) - Drugs in Development, 2021 Nov 30 2021 274 USD 2,500.00
Women Infertility Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 226 USD 2,500.00
Women Infertility - Pipeline Review, H2 2020 Sep 30 2020 232 USD 2,000.00
Women Infertility - Pipeline Review, H2 2019 Dec 16 2019 208 USD 2,000.00
Women Infertility - Pipeline Review, H2 2018 Oct 16 2018 202 USD 2,000.00
Women Infertility - Pipeline Review, H1 2020 Mar 31 2020 217 USD 2,000.00
Women Infertility - Pipeline Review, H1 2018 Apr 24 2018 182 USD 2,000.00
Women Infertility (Women's and Male Health) - Drugs In Development, 2021 Jul 30 2021 265 USD 2,000.00
Wnt Protein (WNT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 41 USD 2,500.00
Wnt Protein (WNT) - Drugs in Development, 2021 Apr 30 2021 35 USD 3,000.00
Wiskott-Aldrich Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 35 USD 2,000.00
Wiskott-Aldrich Syndrome (Immunology) - Drugs in Development, 2021 Apr 30 2021 30 USD 2,000.00
Wilson Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Nov 30 2022 62 USD 2,000.00
Wilson Disease - Pipeline Review, H2 2019 Dec 27 2019 59 USD 2,000.00
Wilson Disease - Pipeline Review, H1 2020 Jun 30 2020 65 USD 2,000.00
Wilson Disease - Pipeline Review, H1 2018 Jun 12 2018 48 USD 2,000.00
Wilson Disease - Drugs in Development, 2021 Nov 30 2021 69 USD 2,000.00
Wilms' Tumor (Nephroblastoma) (Oncology) - Drugs in Development, 2021 Apr 30 2021 35 USD 2,000.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected